Key Takeaways
- • Pivotal Group, a Phoenix private equity investor focused on long-term investments, acquired Precision Science, a Phoenix contract manufacturer of pharmaceuticals, medicated feed additives and supplements for animal health companies.
- • The deal is Pivotal's first acquisition in animal health and forms the base of a planned animal health platform beginning with supplements and pharmaceuticals, according to founder and CEO Francis Najafi.
- • Precision Science, founded in 1989, also provides product research and development services for animal health companies, supplement brands and entrepreneurs.
- • Pivotal is investing in added capacity, technology and staff, including a highly automated 130,000-square-foot facility in North Phoenix that is about two-thirds complete and will add three manufacturing lines and expand into liquids.
Summary
Founded in 1989, Precision Science also provides product research and development for animal health companies, supplement brands and entrepreneurs. The acquisition is Pivotal's first move into the animal health sector. Bryan Vincent serves as CEO of Precision Science.
Founder and CEO Francis Najafi said Pivotal intends to build an animal health platform, starting with supplements and pharmaceuticals. To support that strategy, Pivotal has invested in added capacity, technology and staff. The most significant project is a highly automated 130,000-square-foot facility in North Phoenix, which is about two-thirds complete. The facility is expected to add three manufacturing lines and expand Precision Science's production into liquids.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.